Can digital nutrition help cancer patients fight malnutrition?
NCT ID NCT05544318
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tests whether improved nutritional support, delivered through digital tools and personalized advice, can reduce malnutrition in cancer patients. Around 130 adults with gynecologic, colorectal, or lymphoma cancers will receive either standard dietary advice or enhanced support. The goal is to help patients complete their cancer treatment and improve their quality of life.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- dietary advice
- What this could lead to
- If successful, this could provide a simple, cost-effective way to reduce malnutrition in cancer patients, potentially improving their treatment outcomes and quality of life.
- What could go wrong
- This is a relatively small, early-stage trial (130 participants) testing a behavioral intervention. The results may not apply to all cancer types, and the effect on survival or hospital stays may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Oslo
Oslo, Oslo, 0316, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can a personalized exercise program boost recovery in cancer survivors?
- Could muscle loss predict blood cancer outcomes?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk